We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBBK icon
2501
The Bancorp
TBBK
$2.81B
$2.3K ﹤0.01%
34
OUST icon
2502
Ouster
OUST
$2.28B
$2.29K ﹤0.01%
106
STRT icon
2503
STRATTEC Security
STRT
$358M
$2.29K ﹤0.01%
+30
New +$2.15K
DHT icon
2504
DHT Holdings
DHT
$2.97B
$2.25K ﹤0.01%
184
CRTO icon
2505
Criteo
CRTO
$1.06B
$2.23K ﹤0.01%
+108
New +$2.23K
TDC icon
2506
Teradata
TDC
$2.8B
$2.22K ﹤0.01%
73
+65
+813% +$1.7K
OXY.WS icon
2507
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$2.2K ﹤0.01%
114
CNXN icon
2508
PC Connection
CNXN
$2.04B
$2.19K ﹤0.01%
38
-396
-91% -$23.6K
LADR
2509
Ladder Capital
LADR
$1.25B
$2.18K ﹤0.01%
198
+118
+148% +$1.28K
CMPX icon
2510
Compass Therapeutics
CMPX
$378M
$2.17K ﹤0.01%
405
VTEB icon
2511
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
$2.16K ﹤0.01%
43
AXGN icon
2512
Axogen
AXGN
$2.16B
$2.16K ﹤0.01%
66
MC icon
2513
Moelis & Co
MC
$5.06B
$2.13K ﹤0.01%
31
ITOT icon
2514
iShares Core S&P Total US Stock Market ETF
ITOT
$93.3B
$2.12K ﹤0.01%
14
KIDS icon
2515
OrthoPediatrics
KIDS
$503M
$2.1K ﹤0.01%
118
+93
+372% +$1.63K
INSM icon
2516
Insmed
INSM
$22.9B
$2.09K ﹤0.01%
12
ELME
2517
Elme Communities
ELME
$145M
$2.09K ﹤0.01%
120
DFH icon
2518
Dream Finders Homes
DFH
$1.47B
$2.09K ﹤0.01%
122
+27
+28% +$552
HY icon
2519
Hyster-Yale Materials Handling
HY
$584M
$2.08K ﹤0.01%
70
+55
+367% +$1.81K
AXTI icon
2520
AXT Inc
AXTI
$3.07B
$2.08K ﹤0.01%
+127
New +$1.23K
BBT
2521
Beacon Financial Corp
BBT
$2.51B
$2.06K ﹤0.01%
78
PTON icon
2522
Peloton Interactive
PTON
$2.68B
$2.05K ﹤0.01%
333
-247
-43% -$1.74K
CASS icon
2523
Cass Information Systems
CASS
$712M
$2.04K ﹤0.01%
49
-13
-21% -$529
HVT icon
2524
Haverty Furniture Companies
HVT
$406M
$2.03K ﹤0.01%
+87
New +$1.96K
CCOI icon
2525
Cogent Communications
CCOI
$593M
$2.01K ﹤0.01%
93
+4
+4% +$118

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.